| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911235 | Lung Cancer | 2013 | 6 Pages |
Abstract
S-1 plus cisplatin with bevacizumab is an active and well-tolerated regimen in patients with chemotherapy-naïve non-squamous NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kyoichi Kaira, Yoshio Tomizawa, Reiko Yoshino, Yosuke Miura, Akihiro Yoshii, Yasuki Iwasaki, Yasuhiko Koga, Akihiro Ono, Takeshi Hisada, Koichi Minato, Koji Sato, Toshifumi Kazama, Shinichi Ishihara, Kenya Kohyama, Naoto Fueki, Ryusei Saito,